Usana Health Sciences’ (NYSE:USNA) stock was recently upgraded by Zack Research Services from a “hold” to a “buy” stock, meaning that Zack Research Services feels that Usana stock is set to increase in value and represents an income growth opportunity. As of February 12, the stock is selling at $90.50 per share. Zack set a target price of $98 on the stock. Zack Research Services isn’t the only financial advisor to recommend Usana stock. Roth Capital upped their target price on shares of Usana Health Sciences from $107.00 to $126.00 and gave the stock a “buy” rating in a research note last week.
Some hedge funds are also looking at Usana Health Sciences’ stock to add to their portfolios. Euclidean Technologies Management LLC increased its stake in Usana Health Sciences by 13.7% in the fourth quarter of 2020. Duality Advisers LP purchased $837,000 of Usana stock in the fourth quarter of 2020, and Quantinno Capital Management LP bought a new stake in Usana Health Sciences worth $291,000.
Just a few financial facts Usana Health Sciences: Usana’s stock has a 50-day moving average price of $81.59 and a 200-day moving average price of $78.91. The stock’s 52-week low is $43.01 and its 52-week high is $101.50. The company has a market capitalization of $2.07 billion, a price-to-earnings ratio of 18.25, a P/E/G ratio of 0.96 and a beta of 0.98.
Zack Research’s upgrade was prompted in part by Usana’s positive earnings report, which was released on February 8th. The company reported $1.87 EPS for the quarter, which bests analyst estimates of $1.39 by $0.48. Usana Health Sciences had a net margin of 10.57% and a return on equity of 32.91%. The company had revenue of $310.50 million during the quarter, compared to analyst estimates of $286.71 million. Usana Health Sciences also announced a stock repurchase plan on February 9th. This gives the company the power to buy back $150.00 million in shares. This board of directors’ decision allows Usana to buy up to 8.2% of its stock back via open market purchases.
Usana Health Sciences went public in 1996 and was originally traded on the NASDAQ exchange. The stock moved to the New York Stock Exchange in December 2010.
About Usana Health Sciences
Usana Health Sciences Inc. develops and manufactures high-quality nutritious, personal maintenance and weight supervision products. The company is best known for its Cellsentials line of products. These supplements are deliberate to help individuals look and impression their greatest every day by encouraging good long-time health. Usana Cellsentials are made with vitamins, minerals, antioxidants and supplementary nutrients to help people live their healthiest and best life possible. The company goal and philosophy, as stated on their website is ” if you provender the cells in your body precisely what they want, it will enhance your health. This notion has sustained to fuel our boundless drive to revolutionize and improvement the science of cellular nutrition—tapping a healthy, happy life within spread for all.”
The Utah-based company was originated in 1992 by scientist and medical scientist, Dr. Myron Wentz. The company employs more than 1,900 people in its 80,000-square foot West Valley City industrialized and dissemination center and around the globe. Usana Health Sciences’ products are vended in 25 republics via more than 165,000 direct sales associates. Usana Health Sciences has three product lines–Usana Nutritionals, which includes the Cellsentials line as well as Optimizers, and Digestion/Detox nutritional supplements; Usana Diet & Energy, which includes protein bars, meal replacement shakes and Rev3 energy bars; and Sensé & Celavive personal care, which includes multiple skin, hair and body care products.
Team Usana is a gathering of professional and Olympic athletes who belief Usana products for their health monotonous. To date, Usana Athletes have won 108 Olympic medals, 2449 World Cup medals and 454 world titles. Participants include participants of the US Ski and Snowboard team, Luge team and Speed Skating team.
Usana Health Sciences actively gives back to the community. The company non-profit organization HealthCorps to instruct kids about appropriate nutrition. In 2019, the Usana Foundation’s “Kids Eat” program opened a center to distribute food to children and families in Utah and beyond. Since 2012, the Foundation has bequeathed approximately 25 million mealtimes.
About Zack Investment Research
Zack Investment Research is a well-regarded independent financial research firm with a newsletter that reaches more than 800,000 subscribers. Founded in 1978, the firm gives a rating to each mutual fund and makes recommendations about the stocks within these funds.
For more information about Usana products and the company as a whole, contact (insert contact info).
